[This Week's IPO] March Second Week Demand Forecast and Subscription Schedule

In the second week of this month (March), Tilon and S-Biomedics will conduct demand forecasting targeting institutional investors.

◆Tilon= Established in 2001, Tilon operates businesses including ▲proprietary virtualization technology-based ‘Virtual Desktop Infrastructure (VDI) solutions’ and ‘Desktop as a Service (DaaS) solutions,’ ▲metaverse office platforms, blockchain technology-based electronic document and electronic contract solutions, video conferencing collaboration solutions, and digital data complete deletion solutions.

The total number of shares offered is 600,000, with a desired public offering price band of 25,000 to 30,000 KRW per share. Demand forecasting will be conducted on the 7th and 8th to finalize the public offering price, followed by a two-day general public subscription on the 13th and 14th. The listing is scheduled for the end of next month, with Kiwoom Securities as the lead underwriter.

◆S-Biomedics= S-Biomedics is accelerating clinical development of cell therapies for critical limb ischemia, spinal cord injury, and Parkinson’s disease, strengthening its global growth momentum. The critical limb ischemia treatment using stem cell spheroids is the world’s first to be in Phase 2a clinical trials. It is reported to have superior production of factors related to angiogenesis and immune regulation, as well as excellent effects in pain reduction, promotion of angiogenesis, muscle regeneration, and improvement of lower limb blood flow.

The total number of shares offered is 750,000, with a desired public offering price band of 16,000 to 18,000 KRW per share. Demand forecasting will be conducted on the 8th and 9th to finalize the public offering price, followed by a general public subscription on the 14th and 15th. The lead underwriter is Mirae Asset Securities, and the company aims to be listed within March.

This content was produced with the assistance of AI translation services.